Insider · CIK 0001444783
Mel Sorensen
ceopresidentofficerdirector
Files at GRTX (Galera Therapeutics, Inc.). First filing Nov 24, 2025, latest Nov 24, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1,407 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | GRTXsell Galera Therapeutics, Inc. | $1,407 70,000 shares | -26% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | GRTX Galera Therapeutics, Inc. | SOpen-market sale Common Stock | -70,000 | $0.02 | $1,407 | 195,029 | Nov 24, 2025 |
| May 1, 2025 | GRTX Galera Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +6,000,000 | $0.00 | $0 | 6,000,000 | May 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.